MEDP
Medpace Holdings, Inc.
Stock
$599.47+1.39 (+0.23%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $753M | $713M | $609M | $433M | $388M | $263M | $259M | $202M | $157M | $97M | $92M | $86M |
| Capital expenditures | $46M | $31M | $37M | $37M | $37M | $28M | $31M | $18M | $16M | $12M | $14M | $6.5M |
| Free cash flow | $707M | $682M | $572M | $397M | $351M | $235M | $227M | $184M | $141M | $86M | $78M | $79M |
| Stock-based compensation | $21M | $35M | $26M | $21M | $21M | $14M | $14M | $21M | $6.5M | $4.5M | $9.8M | $22M |
| Buybacks | $299M | $917M | $170M | $144M | $848M | $62M | $98M | $0 | $0 | $156M | $0 | $0 |
| Free cash flow margin | 25.4% | 26.9% | 27.1% | 21.0% | 24.1% | 20.6% | 24.6% | 21.4% | 19.9% | 19.6% | 18.5% | 22.1% |